Last checked at ValiRx Loss Narrows In First Half Amid Reduction In Expenses
ValiRx Loss Narrows In First Half Amid Reduction In Expenses
7 Sep 20 11:55
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Valirx Share News (VAL)
VAL Share
Price
VAL Share
News
VAL Share
Chat26
VAL Share
Trades120
VAL
Live RNS
VAL Share
Charts
VAL Level 2
Console
VAL Live
Share Price
VAL Broker
Ratings
VAL Directors
Deals
VAL Financial
Diary
VAL
Fundamentals
VAL Short
Positions
VAL
Media
VAL Information
Share Price Information for Valirx (VAL)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
25.25
Bid:
25.00
Ask:
25.50
Change:
1.00
(4.12%)
Spread:
0.50 (2.00%)
Open:
24.00
High:
25.25
Low:
24.00
Yest. Close:
24.25
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.7 Sep 20 11:55IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
24 Jul 20 17:23UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump
UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump
23 Jul 20 18:02UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
16 Jul 20 15:57IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus
IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus
6 Jul 20 18:19ValiRx looks to build on portfolio of drug candidates
(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.
6 Jul 20 09:31IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall
IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall
1 Jul 20 13:10IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement
IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement
16 Jun 20 13:58ValiRx Delays Annual Results Amid Covid-19 Pandemic
ValiRx Delays Annual Results Amid Covid-19 Pandemic
8 Jun 20 15:39UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
2 Jun 20 12:57ValiRx enters collaboration agreement for Covid-19 treatment
(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.
2 Jun 20 12:03UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
29 May 20 15:02ValiRx offloads non-core IP to DDTech
(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.
29 May 20 12:59UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair
UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair
27 May 20 14:20UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair
UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair
7 May 20 14:45